Month: March 2026
Sony hikes PS5 prices by up to $150 citing ‘pressures’ in global economy
The PlayStation DualSense controller and PlayStation 5 console. Jakub Porzycki | Nurphoto | Getty Images Sony on Friday said it will raise prices on its range of flagship PlayStation 5 consoles for the second time in less than a year, citing “pressures in the global economic landscape.” In the U.S, the PS5 disc edition will […]
Read More
AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed
AstraZeneca‘s stock jumped nearly 5% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift […]
Read More
Elon Musk’s Grok ordered to stop creating AI nudes by Dutch court as legal pressure mounts
Nikolas Kokovlis | Nurphoto | Getty Images Elon Musk’s xAI and its chatbot Grok have been banned from creating non-consensual AI-generated images of adults and children by a Dutch court, adding to growing legal pressure on the company. Amsterdam’s District Court issued a legal order on Thursday prohibiting xAI from generating and distributing sexual imagery […]
Read More
Infiniti hopes new SUV can turn around fortunes in the U.S.
The 2027 Infiniti QX65. Courtesy: Infiniti Japanese brand Infiniti on Thursday unveiled a new midsize luxury SUV, called the QX65, as it tries to mount a comeback in the U.S. The vehicle will have a 268-horsepower VC-Turbo engine with 286 foot-pounds of torque, as well as dual 12.3-inch displays. The QX65 “accelerates INFINITI into its […]
Read More
Iran war wipes out $100 billion from luxury stocks
A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Major luxury stocks have fallen 15% or more since the Iran war started, and sales in the increasingly important Middle East market could […]
Read More
Springfield Airport Director: Stop using our aviation workers as pawns in a political process
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Squawk Box Brian Weiler, Springfield-Branson National Airport director of aviation, joins ‘Squawk Box’ to discuss the impact of the DHS shutdown on travel. 04:52 an hour ago Source
Read More
Trump’s Iran extension, DHS funding deal, Anthropic’s injunction and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Friday. If you’re as fascinated by the retail sector as I am, you’ll want to read this exclusive from CNBC’s Melissa Repko. I don’t want to spoil it, so just I’ll say that Target isn’t over its boycott woes. Stock futures […]
Read More
The Tech Download: How Russia could profit from Iran war helium supply chain disruption in the chip sector
This report is from this week’s The Tech Download newsletter. Like what you see? You can subscribe here. Helium has emerged as a key focus for the tech sector as industry watchers cast their minds to the implications of a prolonged Iran war. A byproduct of natural gas production, helium is crucial to semiconductor manufacturing and […]
Read More
‘All bets are off’: European borrowing costs hit 15-year highs as investors brace for rate hikes
Crowds of pedestrians and shoppers walk along Weinstrasse toward Marienplatz in Munich, Germany, on March 14, 2026. Michael Nguyen | Nurphoto | Getty Images European government bonds continued to sell off on Friday, building on a rout that has seen multiple countries’ borrowing costs hit multi-decade highs in recent weeks. Thursday saw the yield on […]
Read More
Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern Switzerland, on Sept. 9, 2025. Fabrice Coffrini | AFP | Getty Images Novartis is planning to buy U.S.-based biotech Excellergy for up to $2 billion, betting on a next-generation allergy treatment that may prove […]
Read More